Collaboration and License Agreements (Tables)

9 Months Ended

Sep. 30, 2025

The following table summarizes the aggregate amount paid for the assets acquired by the Company in connection with the Sanofi Agreement as of the Acquisition Date (in thousands):


Upfront	$	100,000
Equipment	1,150
Deposits	2,580
Transaction costs	4,612
Total purchase consideration	$	108,342

The total purchase price was allocated to the acquired assets based on their relative fair values, as of the Acquisition Date as follows (in thousands):


In-process research and development (IPR&D)	$	102,836
Property and equipment	1,119
Prepaid expenses and other current assets (1)	3,975
Assembled workforce	412
Total purchase consideration	$	108,342

__________________________________________________________

(1) Includes acquired cash deposits primarily related to contract manufacturing agreements.